期刊文献+

白假丝酵母ERG11基因突变分析 被引量:9

Analysis of ERG11 gene mutation in Candida albicans
下载PDF
导出
摘要 目的探讨白假丝酵母氟康唑作用的靶酶编码基因(ERG11)突变与氟康唑耐药性的关系。方法选择从尿道、阴道、口咽部、呼吸道、血液和前列腺液分离的10株氟康唑耐药白假丝酵母菌和3株敏感菌株,以抽提的白假丝酵母菌基因组DNA为模板,对ERG11基因序列进行PCR扩增,PCR产物直接DNA序列测定,最后应用BLAST和ClustalW软件对测序结果进行比较。结果13株白假丝酵母菌的ERG11基因序列(以已知序列第1个ATG起始密码的A作为第1个记数单位)共有21个位点发生突变,其中17个同义突变位点和4个错义突变位点;在第348bp位点和第383bp位点,耐药菌株和药物敏感株均可发生D116E和K128T变异;在靶酶活性中心血色素结合区和疏水端螺旋区的对应基因片段,耐药株在第1309bp位点可致V437I变化;在第1320bp位点耐药菌株发生碱基突变,形成A、C基因杂合子,有可能导致N440K变化。结论(1)ERG11基因的D116E和K128T位点变异可能与白假丝酵母菌耐药无关;(2)ERG11基因的V437I和N440K位点的改变,可能与耐药形成有关。 Objective To study the relationship between fluconazole (FCZ)-resistance of Candida albicans and the mutation of ERG11 gene encoding FCZ-targeted enzyme. Method Three strains of FCZ-susceptible and 10 FCZ-resistent C. albicans were isolated from the urethra, vagina, oropharynx, respiratory tract, prostate secretion and blood samples. ERG11 gene was amplified by PCR using C.albicans genomic DNA extracts as the templates and the DNA sequences of the PCR products were determined and compared using BLAST and Clustal-W sofiwares. Results The comparison of ERG11 gene sequences identified mutations at 21 sites in 13 strains, including 17 same-sense and 4 missense mutations. Base substitutions at the sites of 348 bp and 383 bp resulting in D116E and K128T conversion may take place in both drug-resistant and drug-susceptible strains. The point mutation at the site of 1309 bp of FCZ-resistant strain may cause V437I change, and the base inversion at 1320 bp may give rise to A/C heterozygosity mutant ofERGI 1 gene, probably resulting in N440K conversion. Conclusion FCZ-resistance of C. albicans may be associated with point mutations of V437I and N440K in ERGI 1 gene, but not with the point mutations of D166E and KI28T.
出处 《第一军医大学学报》 CSCD 北大核心 2005年第11期1390-1393,共4页 Journal of First Military Medical University
基金 广东省自然科学基金(960358)~~
关键词 白假丝酵母菌 ERG11基因 耐药性 氟康唑 基因突变 Candida albicans ERG 11 gene drug-resistance fluconazole gene mutation
  • 相关文献

参考文献13

  • 1Loeffler J, Hagmeyer L, Hebart H, et al. Rapid detection of point mutations by fluorescence resonance energy transfer and probe melting curves in Candida species [J]. Clin Chem, 2000, 46(5):631-5.
  • 2White TC, Holleman S, Dy F, et ol. Resistance mechanisms in clinical isolates of Candida albicans [J]. Antimicrob Agents Chemother,2002, 46(6): 1704-13.
  • 3王应斌,王宏,郭辉玉,赵永忠,罗深秋.应用M13引物PCR指纹法分析假丝酵母菌氟康唑耐药性[J].第一军医大学学报,2003,23(12):1303-1306. 被引量:1
  • 4Peters S, Koschinsky S, Schwieger F, et ol. Succession of microbial communities during hot composting as detected by PCR-singlestrand-conformation polymorphism-based genetic profiles of small-subunit rRNA genes [J ]. Appl Environ Microbiol, 2000, 66(3): 930-6.
  • 5Perea S, Lopez-Ribot JL, Kirkpatriek WR, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Condida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients [J].Antimicrob Agents Chemother, 2001, 45( 10): 2676-84.
  • 6Aoyama Y, Kudo M, Asai K, et al. Emergence of fluconazoleresistant sterol 14-demethylase P450 (CYP51) in Candida albicans is a model demonstrating the diversification mechanism of P450 [J].Arch Biochem Biophys, 2000, 379(1): 170-1.
  • 7Walsh TJ, Francesconi A, Kasai M, et ol. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi [ J ]. J Clin Microbiol, 1995, 33(12): 3216-20.
  • 8Sanglard D, Ischer F, Koymans L, et ol. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51AI)from azole-resistant Condida 01bicans clinical isolates contribute to resistance to azole antifungalagents[J ]. Antimicrob Agents Chemother,1998, 42(2): 241-53.
  • 9龙丰,张永信,兰和魁,王荫榆,朱德妹,任大明.耐氟康唑白念珠菌ERG11的基因突变[J].中华传染病杂志,2002,20(4):211-214. 被引量:14
  • 10Song JL, Harry JB, Eastman RT, et ol. The Candida 01bicans lanosterol 14-alpha-demethylase (ERG 11) gene promoter is maximally induced after prolonged growth with antifungal drugs [J].Antimicrob Agents Chemother, 2004, 48(4): 1136-44.

二级参考文献10

  • 1[1]Bossche HV, Marichal P, Odds FC. Molecular mechanisms of drug resistance in fungi[J]. Trends Microbiol, 1994, 2: 393-400.
  • 2[2]Bossche HV. Mechanisms ofantifungal resistance[J]. Rev Iberoam Micol, 1997, 14(1): 44-9.
  • 3[3]Pfaller MA, Lockhart SR, Pujol C, et al. Hospital specificity, region specificity, and fluconazole resistance of candida albicans bloodstream isolates[J]. J Clin Microbiol, 1998, 36(6): 1518-29.
  • 4[4]Tamura M, Watanabe K, Mikami Y, et al. Molecular characterization of new clinical isolates of Candida albicans and C.dubliniensis in japan: analysis reveals a new genotype of C. albicans with group iintron[ J ]. J Clin Microbiol, 2001, 39: 4309-15.
  • 5[5]McCullough MJ, Clemons KV, Stevens DA. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea [ J ].J Clin Microbiol, 1997, 37: 417-21.
  • 6[6]National committee for clinical laboratory standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts.Approved standard M27-A. National committee for clinical laboratory standards, Wayne, Pa.
  • 7[7]Imai T, Watanabe K, Tamura YM, et al. Geographic grouping of Cryptococcus neoformans var. gattii by random amplified polymorphic DNA fingerprint patterns and its sequence divergence [ J ]. Clin Lab,2000, 46(7-8): 345-54.
  • 8[8]Franz R, Kelly SL, Lamb DC, et al. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical candida albicans strains[J]. Antimicrob Agents Chemother,1998, 42: 3065-72.
  • 9Sambrook J 金冬雁等(译).分子克隆实验指南(第2版)[M].北京:科学出版社,1996.362-372.
  • 10季海涛,张万年,周有骏,朱杰,吕加国,朱驹.白色念珠菌羊毛甾醇14α-去甲基化酶三维结构分子模型研究[J].生物化学与生物物理学报,1998,30(6):585-592. 被引量:11

共引文献13

同被引文献82

引证文献9

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部